SAMANTHA LOBASSO: Open Payments
NPI 1376213132 · RIVERHEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 54 payments from 27 companies in 2025. Trend: 2023 $78 · 2024 $942 · 2025 $1,709
Food & beverage: $1,344Education: $365
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $303 |
| Novartis Pharmaceuticals Corporation | 10 | $218 |
| Incyte Corporation | 4 | $169 |
| Janssen Biotech, Inc. | 3 | $161 |
| Stemline Therapeutics Inc. | 2 | $140 |
| SEAGEN INC. | 1 | $99 |
| Lilly USA, LLC | 1 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: KISQALI, Orserdu, IMFINZI, DARZALEX, ENHERTU, VERZENIO, TECVAYLI, JAKAFI.
Industry payments across NY — which companies pay providers there.
